President Donald Trump has unveiled a sweeping new initiative with pharmaceutical giant Pfizer aimed at cutting prescription drug costs for millions of Americans.
The programme, known as TrumpRx, will launch in early 2026 and allow patients to purchase medications directly from manufacturers at discounted rates. Under the agreement, Pfizer has pledged to slash prices on select medicines by up to 85% while aligning US drug prices with those in other developed countries through a Most-Favoured-Nation (MFN) pricing model.
